`A Randomized Controlled Trial of Safety and Effectiveness of Depo Provera Intramuscular and Subcutaneous Administration Comparing Lay Lady Health Workers With Clinically-trained Lady Health Visitors in Pakistan

Trial Profile

`A Randomized Controlled Trial of Safety and Effectiveness of Depo Provera Intramuscular and Subcutaneous Administration Comparing Lay Lady Health Workers With Clinically-trained Lady Health Visitors in Pakistan

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Medroxyprogesterone (Primary) ; Medroxyprogesterone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2017 Planned End Date changed from 1 Aug 2018 to 1 Nov 2018.
    • 29 Nov 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
    • 29 Nov 2017 Planned initiation date changed from 15 Nov 2017 to 15 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top